Symbol not found

:IMMU   00:00AM GMT
0.00 (0.00%)
Mergers / Acquisitions

HBM Healthcare Investments: Gilead Sciences To Acquire HBM Portfolio Company Immunomedics

Published: 09/14/2020 05:34 GMT
(IMMU) - Gilead Sciences to Acquire Hbm Portfolio Company Immunomedics.
Gilead Will Acquire Immunomedics for USD 88.00 per Share in Cash.
Anticipated to Close During Q4 of 2020.